Insulet Corporation v. EOFlow Co. Ltd., et al.

Analysis Group was retained to work with counsel at Goodwin Procter and Insulet Corporation (Insulet), the plaintiff in a trade secret misappropriation matter against EOFlow Co., its related entities, and certain employees (EOFlow). Insulet, which manufactures tubeless wearable insulin delivery devices, alleged that three former employees, who joined EOFlow after leaving Insulet, stole trade secrets related to its Omnipod patch pump. Insulet filed suit against EOFlow for intellectual property claims, including a violation of the Defend Trade Secrets Act (DTSA).

An Analysis Group team led by Vice President Yuan Tian supported Managing Principal Justin McLean, who submitted several expert reports and testified at deposition and trial on the damages owed to Insulet from EOFlow’s alleged misappropriation of multiple Insulet trade secrets. 

A jury in the US District Court for the District of Massachusetts found that EOFlow misappropriated Insulet’s trade secrets, awarding Insulet $170 million in compensatory damages, an outcome supported by Mr. McLean’s testimony and damages calculations. The jury also found that the misappropriation of some of Insulet’s trade secrets was willful and awarded an additional $282 million in exemplary damages, for a total damages award of $452 million.